Laura Rosella

Last updated
Laura C. A. Rosella
Alma mater University of Toronto
Scientific career
InstitutionsUniversity of Toronto
Thesis A population based approach to diabetes mellitus risk prediction : methodological advances and practical applications.  (2009)

Laura C. A. Rosella is a Canadian epidemiologist who is an Associate Professor at the Dalla Lana School of Public Health in the University of Toronto. She studies public health and the social determinants of health. Rosella holds a Canada Research Chair in Population Health Analytics.

Contents

Early life and education

Rosella was an undergraduate student at the University of Toronto, where she majored in health science and epidemiology. [1] She remained at the University for her graduate studies, where she evaluated public health risk in people with diabetes mellitus. [2]

Research and career

Rosella is a professor at the Dalla Lana School of Public Health at the University of Toronto. [3] Rosella is the Scientific Director of the Population Health Analytics Laboratory. [4] She has looked to prevent diabetes, through regular screenings and partnerships with provincial health ministries. [1] She developed DPoRT, a Diabetes Population Risk Tool which identifies the optimum cut offs for health screenings to prevent adverse medical outcomes. [5] At the same time, Rosella investigates how people living with diabetes accumulate chronic conditions. She combines her understanding of social and behavioural risk factor data with an understanding of healthcare utilisation to eliminate persistent health inequalities. [1]

From 2018 to 2022, she served as president of the Canadian Society for Epidemiology and Biostatistics. [6]

In November 2020, Rosella joined the Institute for Better Health as the Stephen Family Research Chair in Community Health. [7] In this capacity she looks to improve public health decision making and promote the equitable distribution of healthcare. [7] Rosella has evaluated the use of machine learning in predicting population health. She found that the majority of machine learning applications only made use of traditional data sources, and rarely used big data. [8]

Rosella served as a member of the Ontario COVID-19 Science Advisory Table as a part of the group's Modelling Consensus Table. [9]

Awards and honours

Selected publications

Related Research Articles

<span class="mw-page-title-main">Type 2 diabetes</span> Form of diabetes mellitus

Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, fatigue and unexplained weight loss. Symptoms may also include increased hunger, having a sensation of pins and needles, and sores (wounds) that do not heal. Often symptoms develop slowly. Long-term complications from high blood sugar include heart disease, stroke, diabetic retinopathy, which can result in blindness, kidney failure, and poor blood flow in the lower-limbs, which may lead to amputations. The sudden onset of hyperosmolar hyperglycemic state may occur; however, ketoacidosis is uncommon.

<span class="mw-page-title-main">Epidemiology of diabetes</span>

Globally, an estimated 537 million adults are living with diabetes, according to 2019 data from the International Diabetes Federation. Diabetes was the 9th-leading cause of mortality globally in 2020, attributing to over 2 million deaths annually due to diabetes directly, and to kidney disease due to diabetes. The primary causes of type 2 diabetes is diet and physical activity, which can contribute to increased BMI, poor nutrition, hypertension, alcohol use and smoking, while genetics is also a factor. Diabetes prevalence is increasing rapidly; previous 2019 estimates put the number at 463 million people living with diabetes, with the distributions being equal between both sexes icidence peaking around age 55 years old. The number is projected to 643 million by 2030, or 7079 individuals per 100,000, with all regions around the world continue to rise. Type 2 diabetes makes up about 85-90% of all cases. Increases in the overall diabetes prevalence rates largely reflect an increase in risk factors for type 2, notably greater longevity and being overweight or obese. The prevalence of African Americans with diabetes is estimated to triple by 2050, while the prevalence of whites is estimated to double. The overall prevalence increases with age, with the largest increase in people over 65 years of age. The prevalence of diabetes in America is estimated to increase to 48.3 million by 2050.

Prabhat Jha is an Indian-Canadian epidemiologist currently working in the field of global health.

<span class="mw-page-title-main">Nilanjan Chatterjee</span> Biostatistician

Nilanjan Chatterjee is a Bloomberg Distinguished Professor of Biostatistics and Genetic Epidemiology at Johns Hopkins University, with appointments in the Department of Biostatistics in the Bloomberg School of Public Health and in the Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center in the Johns Hopkins School of Medicine. He was formerly the chief of the Biostatistics Branch of the National Cancer Institute's Division of Cancer Epidemiology and Genetics.

Sharon-Lise Teresa Normand is a Canadian biostatistician whose research centers on the evaluation of the quality of care provided by physicians and hospitals, and on the health outcomes for medical devices and medical procedures. She is a professor in the Department of Health Care Policy at the Harvard Medical School and in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health.

<span class="mw-page-title-main">Elizabeth Barrett-Connor</span>

Elizabeth Louise Barrett-Connor was Chief of the Division of Epidemiology and Distinguished Professor at the University of California, San Diego. She investigated the role of hormones in pathogenesis of cardiovascular disease, diabetes and osteoporosis.

Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

Natalie E. Dean is an American biostatistician specializing in infectious disease epidemiology. Dean is currently an assistant professor of Biostatistics at the University of Florida. Her research involves epidemiological modeling of outbreaks, including Ebola, Zika and COVID-19.

Nishi Chaturvedi is a Professor of Clinical Epidemiology at University College London. Her research considers how ethnicity and lifestyle impact people's risk factors for disease. During the COVID-19 pandemic, Chaturvedi explained that the increased mortality rate for people from black and minority ethnic backgrounds was due to societal inequality and how this intersects with healthcare.

<span class="mw-page-title-main">Cuilin Zhang</span> Chinese epidemiologist and physician-scientist

Cuilin Zhang is a Chinese-American epidemiologist and physician-scientist researching the roles of genetic and environmental factors in the pathogenesis of gestational diabetes, type 2 diabetes, and obesity and health consequences of these complications. Zhang is a senior investigator and acting chief of the epidemiology branch at the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Dr. Shelley Deeks, MD, MHSc, FRCPC, FFAFPM, is a Canadian public health expert who is the chair of the National Advisory Committee on Immunization. Her advertised "specialities include communicable disease control, outbreak investigations, vaccine safety, epidemiology and program evaluation." She is a fellow of the Royal College of Physicians of Canada and the Australian Faculty of Public Health Medicine. Deeks was the executive lead in Ontario's COVID-19 pandemic response in 2020 in her role at Public Health Ontario.

<span class="mw-page-title-main">David Fisman</span> Canadian epidemiologist

David N. Fisman is a University of Toronto professor in the area of epidemiology at the Dalla Lana School of Public Health. He also works as an infectious disease specialist and consultant at the University Health Network.

Scarlett Bellamy is an American public health researcher who is a Professor of the Department of Epidemiology and Biostatistics at Drexel University. At Drexel she is Associate Dean of Diversity, Inclusion and Faculty Development.

Lynda D. Lisabeth is an American epidemiologist who is Professor and Senior Associate Dean for Faculty Affairs in the School of Public Health at the University of Michigan. Her research considers the epidemiology of stroke in the United States, and she has worked with the National Institute of Neurological Disorders and Stroke on the advancement of stroke research.

Rulan S. Parekh is an American-Canadian clinician-scientist and nephrologist. She is the vice president of research, education and innovation at Women's College Hospital and former senior scientist in Child Health Evaluative Sciences and Associate Chief of Clinical Research at SickKids.

Lorna E. Thorpe is an American epidemiologist who is a professor and Director of the Division of Epidemiology at NYU Langone Health. She serves as Vice Chair of Strategy and Planning in the Department of Population Health and on the Board of the American College of Epidemiology.

Anna Banerji M.D., O. Ont. is a Toronto infectious disease doctor, tropical disease specialist, pediatrician, public health specialist, academic, and activist. She is the founder and chair of both the North American Refugee Health Conference in Canada and the Indigenous Health Conference, and the co-founder of the Society of Refugee Healthcare Providers. She was awarded the Dr Peter Bryce Henderson for her advocacy for Indigenous children.

<span class="mw-page-title-main">Monica Malta</span> Social Epidemiologist

Monica Malta is a Brazilian researcher who works mostly to address health inequalities faced by LGBTQ persons. She is currently a professor at the University of Toronto and a scientist at the Centre for Addiction and Mental Health. She was elected a TED fellow in 2022.

<span class="mw-page-title-main">David Guwatudde</span> Ugandan academic and researcher

Prof David Guwatudde is a Ugandan academic and researcher. He is currently a professor of Epidemiology and Biostatistics in the Department of Epidemiology and Biostatistics at the School of Public Health, Makerere University College of Health Sciences.

Jessie Elisabeth Wells is a New Zealand biostatistician, and is a professor emerita at the University of Otago, specialising in epidemiology and mental health research.

References

  1. 1 2 3 "BBDC Member Profile". Banting & Best Diabetes Centre. 2019-01-07. Retrieved 2021-05-30.
  2. ↑ Rosella, Laura C. A (2011). A population based approach to diabetes mellitus risk prediction: methodological advances and practical applications (Thesis). Ottawa: Library and Archives Canada = Bibliothèque et Archives Canada. OCLC   785764075.
  3. ↑ "Rosella, Laura C." Dalla Lana School of Public Health. Retrieved 2021-05-30.
  4. ↑ "Our Team". Population Health Analytics Laboratory | Toronto, ON. Retrieved 2021-05-30.
  5. ↑ Rosella, Laura C.; Manuel, Douglas G.; Burchill, Charles; Stukel, Thérèse A.; PHIAT-DM team (July 2011). "A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT)". Journal of Epidemiology and Community Health. 65 (7): 613–620. doi:10.1136/jech.2009.102244. ISSN   1470-2738. PMC   3112365 . PMID   20515896.
  6. ↑ "Laura Rosella". University of Toronto. Retrieved 2024-08-21.
  7. 1 2 "IBH Welcomes New Research Chairs". Institute for Better Health. Retrieved 2021-05-30.
  8. ↑ Morgenstern, Jason Denzil; Buajitti, Emmalin; O'Neill, Meghan; Piggott, Thomas; Goel, Vivek; Fridman, Daniel; Kornas, Kathy; Rosella, Laura C. (2020-10-27). "Predicting population health with machine learning: a scoping review". BMJ Open. 10 (10): e037860. doi:10.1136/bmjopen-2020-037860. ISSN   2044-6055. PMC   7592293 . PMID   33109649.
  9. ↑ "Our Partners". Ontario COVID-19 Science Advisory Table . Archived from the original on 2022-09-02. Retrieved 2022-09-02.
  10. ↑ "PHO Scientist Wins Award from Canadian Society for Epidemiology and Biostatistics". Public Health Ontario. Archived from the original on 2021-06-02. Retrieved 2021-05-30.
  11. ↑ "Past Award Winners – Early Career – Society for Epidemiologic Research". 18 June 2014. Retrieved 2021-05-30.
  12. ↑ "Laura Rosella named a recipient of Canada's Top 40 Under 40". Dalla Lana School of Public Health. 2018-06-27. Retrieved 2021-05-30.
  13. ↑ "Three Out of Five DLSPH Projects Earn Connaught Community Project Awards". Dalla Lana School of Public Health. 2020-09-25. Retrieved 2024-08-21.
  14. ↑ "Laura Rosella". Canadian Institute for Advanced Research. 2023-07-09. Retrieved 2024-08-21.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.